The neuromuscular disease myotonic dystrophy (DM) is caused by microsatellite repeat expansions at two different genomic loci. Mutant DM transcripts are retained in the nucleus together with the muscleblind (Mbnl) proteins, and these abnormal RNAs somehow interfere with pre-mRNA splicing regulation. Here, we show that disruption of the mouse Mbnl1 gene leads to muscle, eye, and RNA splicing abnormalities that are characteristic of DM disease. Our results support the hypothesis that manifestations of DM can result from sequestration of specific RNA binding proteins by a repetitive element expansion in a mutant RNA.
Loss of cone function in the central retina is a pivotal event in the development of severe vision impairment for many prevalent blinding diseases. Complete achromatopsia is a genetic defect resulting in cone vision loss in 1 in 30,000 individuals. Using adeno-associated virus (AAV) gene therapy, we show that it is possible to target cones and rescue both the cone-mediated electroretinogram response and visual acuity in the Gnat2 cpfl3 mouse model of achromatopsia.The human retina has approximately 6 million cone photoreceptors, concentrated predominantly in the central retina, which are responsible for high-resolution and color vision. Complete achromatopsia is a disease involving cones that results in permanent central vision loss, deficient cone-mediated electroretinogram (ERG) signal and color blindness, with affected individuals usually having a visual acuity of 20/200 or less 1-3 . Because these individuals only have functioning rods, they experience extreme light sensitivity and daytime blindness 1-3 , owing to the fact that the rods become light saturated. In humans, mutations in cyclic nucleotide-gated channel β-3 (or α-3) and guanine nucleotide α-transducin (GNAT2) genes can give rise to this phenotype 1-3 . The Gnat2 cpfl3 homozygous mouse 4 has a single base substitution inducing a missense mutation (D200N) in cone α-transducin, which results in little or no light-adapted (cone-mediated) ERG response and a normal dark-adapted ERG response, similar to observations in the human form of complete achromatopsia 5 . The GNAT2 mutant form of achromatopsia in humans, and Gnat2 cpfl3 mice, results in a disruption of heterotrimeric G-protein signaling 2,4 , which couples light-activated cone visual pigments to the visual transduction cascade.To develop an AAV vector system that could effectively transduce cones, we first needed a promoter that would efficiently target expression in cones. Previous studies 6,7 have demonstrated that mice transgenic for sequences upstream of the red/green opsin genes, containing a core promoter with a locus control region 6,8,9 , can direct the expression of a reporter gene to both classes of cones in the mouse retina. On the basis of these considerations, we selected a 2.1-kb human red/green opsin promoter construct (PR2.1) to provide cone specificity for our vector. PR2.1 is composed of bases spanning −4,564 to −3,009 and −496 to 0 of the human red cone opsin gene 6 . When incorporated into an AAV vector and packaged in serotype-5 capsids (AAV5-PR2.1-GFP), this promoter targeted green fluorescent protein (GFP) expression to mouse cones when injected subretinally, as shown by the colocalization of GFP with mouse cone arrestin (Fig. 1a). Subsequently, we created an AAV5 vector in which the wild-type mouse cone α-transducin cDNA (Gnat2) was under control of the PR2.1 promoter (AAV5-PR2.1-Gnat2).We then injected 4 × 10 10 vector genome-containing particles of AAV5-PR2.1-Gnat2 into the subretinal space of Gnat2 cpfl3 mouse eyes, from two litters of 10 and 11 mice, on postna...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.